Clinical Trials on Portal Hypertension. in South Africa

Total 607 results

  • ppharmaand GmbH
    Bristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaborators
    Active, not recruiting
    A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)
    Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response
    United States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
  • Radiation Therapy Oncology Group
    National Cancer Institute (NCI); NRG Oncology
    Completed
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Lung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ
    United States, Canada
  • California Pacific Medical Center Research Institute
    University of Pittsburgh; Duke University; National Institute on Aging (NIA); University... and other collaborators
    Recruiting
    Trial of Parkinson's And Zoledronic Acid (TOPAZ)
    Parkinson Disease | Osteoporosis | Parkinsonism | Multiple System Atrophy | Progressive Supranuclear Palsy | Parkinson's Disease and Parkinsonism | Dementia With Lewy Bodies | Atypical Parkinsonism | Vascular Parkinsonism
    United States
  • MacroGenics
    Active, not recruiting
    A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors (Tamarack)
    Melanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditions
    Spain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
  • National Cancer Institute (NCI)
    Recruiting
    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
    Mucosal Melanoma | Anal Melanoma | Bladder Melanoma | Cervical Melanoma | Esophageal Melanoma | Gallbladder Melanoma | Mucosal Melanoma of the Head and Neck | Mucosal Melanoma of the Urinary System | Oral Cavity Mucosal Melanoma | Penile Mucosal Melanoma | Rectal Melanoma | Recurrent Mucosal Melanoma | Sinonasal... and other conditions
    United States, Canada
  • University of Nebraska
    Recruiting
    Integrated Cancer Repository for Cancer Research (iCaRe2)
    Melanoma | Sarcoma | Kidney Cancer | Leukemia | Breast Cancer | Laryngeal Cancer | Hypopharyngeal Cancer | Nasopharyngeal Cancer | Multiple Myeloma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Small Intestine Cancer | Ovarian Cancer | Lynch Syndrome | Lung Cancer | Rectal Cancer | Prostate Cancer | Gastrointestinal... and other conditions
    United States
  • National Cancer Institute (NCI)
    Active, not recruiting
    Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
    Malignant Solid Neoplasm | Nasopharyngeal Carcinoma | Adenoid Cystic Carcinoma | Transitional Cell Carcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Chordoma | Gestational Trophoblastic Tumor | Pseudomyxoma Peritonei | Cervical Adenocarcinoma | Vaginal Adenocarcinoma | Vaginal Squamous Cell... and other conditions
    United States, Guam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe